Want to join the conversation?
$UTX reaffirmed its 1Q16 adjusted EPS guidance of $1.35-1.40 and its 2016 adjusted EPS outlook of $6.30-6.60. $UTX expects organic sales growth of 5-8% at compound annual growth rate from 2016 through 2020 and beyond, well above projections for global GDP growth. $UTX continues to expect free cash flow of 90-100% of net income for 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?